### ü´Å Pulmonology: Sarcoidosis-Related Hilar Lymphadenopathy Diagnosis

#### ‚úÖ True Statements
1. **Stage I pulmonary sarcoidosis** is defined by the presence of **hilar lymphadenopathy with normal lung parenchyma**.
2. **Stage I pulmonary sarcoidosis** is generally **asymptomatic**.
3. Approximately **50% of patients with pulmonary sarcoidosis** are **asymptomatic**, with the disease detected incidentally on **chest imaging** performed for unrelated indications.
4. On **chest CT scan**, **stage I pulmonary sarcoidosis** may show **marked enlargement of lymph nodes in both hila**.
5. On **chest CT scan**, **stage I pulmonary sarcoidosis** may show **enlargement of a subcarinal lymph node**.

#### üí¨ Extra
1. The referenced chest CT scan slice was taken just below the **carina**.
4. White arrows in the figure highlight enlarged hilar lymph nodes.
5. A black arrow in the figure highlights the enlarged subcarinal lymph node.

#### üè∑Ô∏è Tags
#Pulmonology #AmbulatoryCare #Sarcoidosis #ChestCT #HilarLymphadenopathy

#### üìö Reference
Baughman RP, Culver DA, Judson MA. Sarcoidosis. *Lancet*. 2011;378(9785):1155-1167. PMID: 21813429 doi:10.1016/S0140-6736(10)62141-2

#### üÜî Question ID
PMVDX24010

#### üïí Last Updated
February 2025

---

#### üìñ Related Text
MKSAP 19: Pulmonary Medicine ‚Äî Diffuse Parenchymal Lung Disease, Sarcoidosis, Sarcoidosis

---

### üìò Related Text Derivations

#### ‚úÖ True Statements ‚Äî Sarcoidosis
1. **Sarcoidosis** is a **granulomatous disease of unknown cause** that can affect **any organ system**.
2. The **prevalence of sarcoidosis** is approximately **10 to 20 per 100,000 individuals**.
3. More than **90% of patients with sarcoidosis** have **lung involvement**.
4. Many patients with **sarcoidosis** are **asymptomatic**, with **lung involvement** incidentally detected on **chest radiography** performed for other reasons.
5. On **CT scan**, sarcoidosis can show **pulmonary parenchymal disease**, **intrathoracic lymphadenopathy**, or both.
6. The presence of **nodules along bronchovascular bundles** on **high-resolution CT (HRCT)** suggests **sarcoidosis**.
7. **Findings on chest radiograph** in sarcoidosis can help predict the **probability of spontaneous resolution**.
8. **Pulmonary function testing** in sarcoidosis is typically **abnormal** and may show **obstructive**, **restrictive**, or **mixed** patterns.
9. **Sarcoidosis is a diagnosis of exclusion**, typically requiring **bronchoscopic biopsy** of **lymph node or pulmonary parenchyma tissue**.
10. The diagnosis of **sarcoidosis** is made by identifying **noncaseating granulomas**, excluding **infectious causes** such as **mycobacteria** and **fungi**, excluding **other systemic granulomatous diseases**, and ideally demonstrating **involvement of more than one organ system**.
11. The **primary treatment of sarcoidosis** is **glucocorticoids**.
12. Many patients with **sarcoidosis** do not require treatment, as **spontaneous resolution without therapy is common**.
13. **Spontaneous resolution** in sarcoidosis is related to the **radiographic stage of disease**.
14. The **decision to treat sarcoidosis** should be based on **symptoms and organ dysfunction**, not on **radiographic findings**.
15. In **asymptomatic sarcoidosis without organ dysfunction**, **observation is appropriate**.
16. In **sarcoidosis requiring treatment**, **glucocorticoid therapy** is appropriate.
17. For patients with **sarcoidosis and severe or prolonged symptoms**, the **adverse effects of long-term glucocorticoids** should be considered, and **adjunctive glucocorticoid-sparing therapies** may be used.
18. The development of **pulmonary hypertension** in patients with **sarcoidosis** is a **poor prognostic indicator**, with a **median survival of approximately 3 years**.
19. **Pulmonary consultation** should be considered for patients with **persistent sarcoidosis**.
20. For patients with **sarcoidosis and pulmonary hypertension** or **severe disease causing significant activity limitation**, evaluation for **lung transplantation** is appropriate.

#### üí¨ Extra
6. **Nodules along bronchovascular bundles** are a classic HRCT finding that supports the diagnosis of sarcoidosis.
9. Exceptions to biopsy requirement include specific clinical syndromes of sarcoidosis (e.g., L√∂fgren syndrome, Heerfordt syndrome).
17. Examples of glucocorticoid-sparing agents include **methotrexate** and **azathioprine**, though not named in the provided text.

---

#### üè∑Ô∏è Tags
#Pulmonology #Sarcoidosis #GranulomatousDisease #PulmonaryFunctionTesting #Glucocorticoids #PulmonaryHypertension #LungTransplantation #RadiographicStaging #BiopsyExceptions

---

#### üñºÔ∏è Supplemental Figures
<figure>
  <img src="Diagnose sarcoidosis-related hilar lymphadenopathy on a chest CT scan.jpg" alt="Diagnose sarcoidosis-related hilar lymphadenopathy on a chest CT scan.jpg">
  <figcaption><strong>Chest CT scan showing sarcoidosis-related hilar lymphadenopathy.</strong> White arrows = bilateral hilar lymph nodes; black arrow = subcarinal lymph node. Abbreviations: AAo = ascending aorta; DAo = descending aorta; LMB = left mainstem bronchus; RMB = right mainstem bronchus; RPA = right pulmonary artery.</figcaption>
</figure>

<figure>
  <img src="Hilar Lymphadenopathy on Chest Radiograph in Stage I Pulmonary Sarcoidosis.jpg" alt="Hilar Lymphadenopathy on Chest Radiograph in Stage I Pulmonary Sarcoidosis.jpg">
  <figcaption><strong>Hilar Lymphadenopathy on Chest Radiograph in Stage I Pulmonary Sarcoidosis.</strong> Chest radiograph showing stage I pulmonary sarcoidosis with hilar lymphadenopathy and normal lung parenchyma.</figcaption>
</figure>

---

#### üóæ Supplemental Tables

<!--Radiographic Characteristics and Staging in Pulmonary Sarcoidosis-->
<table>
  <caption><strong>Radiographic Characteristics and Staging in Pulmonary Sarcoidosis</strong></caption>
  <thead>
    <tr>
      <th>Stage</th>
      <th>Radiographic Pattern</th>
      <th>Clinical Course and Comments</th>
    </tr>
  </thead>
  <tbody>
    <tr><td>0</td><td>Normal</td><td>&nbsp;</td></tr>
    <tr><td>I</td><td>Hilar lymphadenopathy with normal lung parenchyma</td><td>&gt;90% rate of spontaneous resolution without treatment</td></tr>
    <tr><td>II</td><td>Hilar lymphadenopathy with abnormal lung parenchyma</td><td>Approximately 50% rate of spontaneous improvement without treatment</td></tr>
    <tr><td>III</td><td>No lymphadenopathy with abnormal lung parenchyma</td><td>Approximately 20% rate of spontaneous improvement without treatment</td></tr>
    <tr><td>IV</td><td>Parenchymal changes with fibrosis and architectural distortion</td><td>&nbsp;</td></tr>
  </tbody>
</table>

#### ‚úÖ True Statements ‚Äî Radiographic Characteristics and Staging in Pulmonary Sarcoidosis
1. **Stage 0 sarcoidosis** shows a **normal chest radiograph**.
2. **Stage I sarcoidosis** shows **hilar lymphadenopathy with normal lung parenchyma** and has a **>90% rate of spontaneous resolution without treatment**.
3. **Stage II sarcoidosis** shows **hilar lymphadenopathy with abnormal lung parenchyma** and has an **approximately 50% rate of spontaneous improvement without treatment**.
4. **Stage III sarcoidosis** shows **no lymphadenopathy with abnormal lung parenchyma** and has an **approximately 20% rate of spontaneous improvement without treatment**.
5. **Stage IV sarcoidosis** shows **parenchymal changes with fibrosis and architectural distortion**.

---

<!--Clinical Presentations of Sarcoidosis That Do Not Require Biopsy-->
<table>
  <caption><strong>Clinical Presentations of Sarcoidosis That Do Not Require Biopsy</strong></caption>
  <thead>
    <tr>
      <th>Syndrome</th>
      <th>Additional Findings/Symptoms</th>
    </tr>
  </thead>
  <tbody>
    <tr><td>Asymptomatic bilateral hilar lymphadenopathy</td><td>No evidence of fevers, malaise, weight loss, or night sweats to suggest a malignancy or infection</td></tr>
    <tr><td>L√∂fgren syndrome</td><td>Bilateral hilar lymphadenopathy, migratory polyarthralgia, erythema nodosum, fever</td></tr>
    <tr><td>Heerfordt syndrome</td><td>Anterior uveitis, parotitis, fever (uveoparotid fever), facial nerve palsy</td></tr>
  </tbody>
</table>

#### ‚úÖ True Statements ‚Äî Clinical Presentations of Sarcoidosis That Do Not Require Biopsy
1. **Asymptomatic bilateral hilar lymphadenopathy** without fevers, malaise, weight loss, or night sweats does not require biopsy for sarcoidosis diagnosis.
2. **L√∂fgren syndrome** does not require biopsy for sarcoidosis diagnosis and is characterized by **bilateral hilar lymphadenopathy, migratory polyarthralgia, erythema nodosum, and fever**.
3. **Heerfordt syndrome** does not require biopsy for sarcoidosis diagnosis and is characterized by **anterior uveitis, parotitis, fever (uveoparotid fever), and facial nerve palsy**.